CTLA4 and neoplasm: Therefore, based on the detection of the composition of infiltrated immune cells in the TME, targeting the dominant infiltrated immune cell population is a rational strategy to precisely suppress tumor growth rather than simply depending on blockade of CTLA4 or the PD1/PDL1 axis.